“In single-dose toxicology studies conducted in adult male :CD1 mice with study durations up to 6 months, the IV administration of ROCTAVIAN at dose levels of 6.53 × 1013 vg/kg and higher resulted in dose-dependent adverse histopathologic findings in the heart”
✓ VerifiedFDA summary basis for approval, p. 12Source ↗
Pivotal GLP studies
Two GLP single-dose IV studies in CD1 male mice (up to 26 weeks); 3-month single-dose male monkey study; germline transmission studies
“Then, two GLP single-dose studies were conducted in normal CD1 mice with observation periods of up to 26 weeks, and with doses ranging from 6E12 to 2E14 vg/kg.”